🇺🇸 FDA
Patent

US 8367690

Aminopyridine derivatives having aurora a selective inhibitory action

granted A61KA61K31/535A61P

Quick answer

US patent 8367690 (Aminopyridine derivatives having aurora a selective inhibitory action) held by Vertex Pharmaceuticals Incorporated expires Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Feb 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
6
CPC classes
A61K, A61K31/535, A61P, A61P35/00, A61P35/02